Elscint develops first connectivity productIsraeli medical imaging vendor Elscint hopes to unveil its first home-grown medical image management product this year, according to sources at the Haifa company. Elscint is developing a mid-range
Israeli medical imaging vendor Elscint hopes to unveil its first home-grown medical image management product this year, according to sources at the Haifa company. Elscint is developing a mid-range connectivity product that would occupy a price point below that of Agfa's Impax PACS product, to which Elscint has worldwide marketing rights.
Elscint has been further behind most of its multimodality competitors in offering PACS and image management products. The company has been more active in the last two years, however, forming a connectivity group in 1995 and inking its marketing agreement with Agfa several months later.
The connectivity product under development is not a full-scale PACS network, but is a mid-tier offering designed for smaller hospitals, according to the source. It will include features for remote reading, image archiving, and other functions. Elscint hopes to debut the product some time this year.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.